InfuSystems Holdings Inc (INFU) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.017x

Based on the latest financial reports, InfuSystems Holdings Inc (INFU) has a cash flow conversion efficiency ratio of 0.017x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($970.00K) by net assets ($58.75 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See InfuSystems Holdings Inc (INFU) net asset quality to measure how much of total assets are equity-financed.

InfuSystems Holdings Inc - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how InfuSystems Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check InfuSystems Holdings Inc (INFU) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

InfuSystems Holdings Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of InfuSystems Holdings Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Reit Azorim HF Living Ltd
TA:AZRT
0.001x
Black Spade Acquisition II Co Unit
NASDAQ:BSIIU
-0.002x
Chia Chang Co Ltd
TW:4942
0.031x
Vestland Berhad
KLSE:0273
-0.103x
Draganfly Inc
NASDAQ:DPRO
-0.054x
CAMP4 THERAPEUTICS CORPORATION
NASDAQ:CAMP
-0.355x
Aimia Inc
TO:AIM
0.110x
La Finca Global Assets SOCIMI S.A.
MC:YLFG
0.140x

Annual Cash Flow Conversion Efficiency for InfuSystems Holdings Inc (2005–2025)

The table below shows the annual cash flow conversion efficiency of InfuSystems Holdings Inc from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see InfuSystems Holdings Inc market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $57.33 Million $24.41 Million 0.426x +19.72%
2024-12-31 $57.53 Million $20.46 Million 0.356x +65.73%
2023-12-31 $52.30 Million $11.22 Million 0.215x -41.20%
2022-12-31 $48.00 Million $17.52 Million 0.365x -3.83%
2021-12-31 $48.27 Million $18.32 Million 0.379x -23.75%
2020-12-31 $40.75 Million $20.28 Million 0.498x -19.90%
2019-12-31 $22.33 Million $13.88 Million 0.621x +11.48%
2018-12-31 $20.44 Million $11.39 Million 0.557x +127.47%
2017-12-31 $30.95 Million $7.58 Million 0.245x +57.01%
2016-12-31 $50.69 Million $7.91 Million 0.156x +13.42%
2015-12-31 $51.28 Million $7.05 Million 0.138x -11.92%
2014-12-31 $46.45 Million $7.25 Million 0.156x -10.59%
2013-12-31 $42.72 Million $7.46 Million 0.175x +28.20%
2012-12-31 $40.01 Million $5.45 Million 0.136x -23.69%
2011-12-31 $40.16 Million $7.17 Million 0.179x +40.62%
2010-12-31 $85.14 Million $10.81 Million 0.127x +6.56%
2009-12-31 $81.47 Million $9.71 Million 0.119x -12.43%
2008-12-31 $80.07 Million $10.90 Million 0.136x +113.78%
2007-12-31 $68.76 Million $4.38 Million 0.064x +554.54%
2006-12-31 $65.15 Million $-912.35K -0.014x -106.93%
2005-12-31 $-376.00 $-76.00 0.202x --

About InfuSystems Holdings Inc

NYSE MKT:INFU USA Medical Devices
Market Cap
$194.96 Million
Market Cap Rank
#17243 Global
#4044 in USA
Share Price
$9.66
Change (1 day)
-2.82%
52-Week Range
$5.60 - $10.79
All Time High
$22.92
About

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment … Read more